Investments

Co-Investment

WS Audiology

Denmark

01 January 2022

Healthcare & life science

Healthcare & life science

Headquartered in Denmark and Singapore as a result of the merger of Sivantos and Widex in 2019, WS Audiology (WSA) is the #2 global hearing aids player. The company develops, manufactures and sells hearing aids products through a global multi-channel strategy and owns a multi-brand portfolio (Signia, Widex, Rexton, Audio Services, etc.). WSA sells its products in more than 125 countries and employs over 10,000 people worldwide.

https://www.wsa.com/en/

https://twitter.com/ws_audiology

https://www.linkedin.com/company/wsaudiology/

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA

Co-Investment

Expertise
Co-Investment

Team

Investments

WS Audiology